Once-weekly, high-dose semaglutide injections are increasingly prescribed in Singapore for individuals seeking medical support for weight loss. This GLP-1 receptor agonist, developed by Novo Nordisk, is recognised for its role in appetite regulation and metabolic health. It is often recommended for patients who have not achieved satisfactory results from diet and exercise alone.
In Singapore, high-dose semaglutide injections are provided under doctor supervision as part of a structured weight management program. This guide explains how once-weekly semaglutide therapy works, what to expect before and during treatment, and the key considerations for patients exploring this option.
Continue reading for an overview of treatment eligibility, expected outcomes, dosing protocols, safety information, and comparisons with other medical weight loss therapies available locally.
Once-weekly high-dose semaglutide therapy refers to a prescription weight loss injection containing semaglutide, a GLP-1 receptor agonist. This medication is administered as a subcutaneous injection once per week and is formulated at a higher dose than semaglutide injections used for diabetes management.
Developed by Novo Nordisk, this therapy is recognised for its effects on appetite regulation and metabolic health. In Singapore, once-weekly high-dose semaglutide is prescribed as part of a doctor-supervised weight management program for adults who meet specific body mass index (BMI) criteria and require medical intervention for weight loss.
The weekly dosing protocol allows for convenient home administration following instruction from a healthcare provider. Semaglutide acts on the body’s appetite-regulating pathways, helping to reduce hunger and overall calorie intake while supporting gradual, sustained weight reduction.
The higher-dose, weekly formulation is distinct from other semaglutide products and is specifically approved for obesity and overweight management, not just for diabetes control.
High-dose semaglutide therapy for weight loss is formulated at 1.7mg or 2.4 mg per weekly injection. This is a higher dose than the standard semaglutide products used primarily for diabetes management, which are typically administered at 0.25 mg to 1 mg weekly.
While both high-dose and standard-dose semaglutide share the same active ingredient and mechanism of action, the increased dose in weight management protocols is designed to provide greater appetite suppression and more significant weight reduction.
In clinical settings, this higher-dose, once-weekly formulation is reserved for adults who meet the criteria for medical weight loss, such as those with a higher body mass index or weight-related health conditions.
The distinction between standard and high-dose semaglutide is important, as only the higher-dose formulation is approved in Singapore for the treatment of obesity and overweight, while the lower doses remain indicated for glucose control in diabetes.
Patients considering once-weekly semaglutide therapy for weight loss will be assessed by their doctor to determine the most suitable formulation, based on health goals and clinical guidelines.
Once-weekly semaglutide is a GLP-1 receptor agonist, which means it acts on the same biological pathways as the natural hormone glucagon-like peptide-1. By binding to GLP-1 receptors, semaglutide helps regulate appetite and food intake.
This medication slows the rate at which food leaves the stomach, leading to a prolonged sense of fullness after meals. It also acts on appetite centers in the brain to reduce hunger and decrease cravings for food. As a result, patients generally experience a reduction in daily calorie intake, which supports gradual and sustained weight loss over time.
Clinical research has shown that GLP-1 receptor agonists not only help with weight reduction but can also improve metabolic markers such as blood sugar, cholesterol, and blood pressure. For individuals with prediabetes or type 2 diabetes, semaglutide may offer additional benefits for glycemic control.
The effectiveness of once-weekly semaglutide therapy depends on consistent use, regular follow-up with a healthcare provider, and the incorporation of healthy eating and physical activity. Most patients are advised to view medication as just one part of a broader weight management program, supported by ongoing medical supervision and lifestyle modification.
Clinical trials and real-world studies have evaluated the effectiveness of once-weekly high-dose semaglutide injections for weight management. In Singapore, this therapy is prescribed to patients who require additional medical support to achieve and maintain a healthy weight.
Research has shown that high-dose semaglutide, administered as a 2.4 mg weekly injection, can lead to significant reductions in body weight when used together with lifestyle changes and regular medical supervision. The benefits of this therapy have been documented both internationally and in local clinical settings.
The effectiveness of once-weekly high-dose semaglutide injections for weight loss has been established in multiple large-scale clinical trials, most notably the STEP program.
The STEP 1 trial (New England Journal of Medicine, 2021; https://www.nejm.org/doi/full/10.1056/NEJMoa2032183) showed that adults receiving 2.4 mg of semaglutide weekly achieved an average weight reduction of 14.9% of their initial body weight after 68 weeks, compared to 2.4% for those receiving placebo.
Additional research, including the STEP 3 trial (JAMA, 2021; https://jamanetwork.com/journals/jama/fullarticle/2777025), evaluated once-weekly semaglutide alongside intensive behavioral therapy and demonstrated even greater weight loss, with many participants losing more than 16% of their starting weight.
Long-term findings from the STEP 5 trial (Nature Medicine, 2022; https://www.nature.com/articles/s41591-022-02026-4) confirmed that significant weight loss can be maintained for up to two years in patients who continue treatment with ongoing medical supervision and lifestyle modification.
Beyond weight loss alone, these studies consistently report improvements in metabolic health markers, including blood sugar control, cholesterol levels, and blood pressure. High-dose semaglutide therapy has also been linked to reduced cardiovascular risk factors in individuals with overweight or obesity.
International guidelines now recognise once-weekly high-dose semaglutide as a clinically validated approach for the medical management of obesity and overweight, particularly when combined with dietary changes, increased physical activity, and regular doctor supervision.
Clinical experience in Singapore echoes these international results. Patients prescribed this therapy as part of a structured, doctor-led weight management program often achieve substantial and sustainable weight reduction, as well as improvements in overall metabolic health.
Individual results with once-weekly high-dose semaglutide injections can vary based on several key factors. One of the most significant is starting body mass index (BMI); individuals with higher BMI often see more substantial absolute weight loss compared to those with lower starting weights.
Adherence to the treatment plan is also crucial. Patients who consistently follow their dosing schedule, attend regular medical reviews, and stay engaged with their weight management program are more likely to achieve and maintain significant weight reduction.
Lifestyle changes play a major role in the effectiveness of this therapy. Combining semaglutide injections with healthy eating habits, increased physical activity, and behavioral modifications supports better long-term outcomes than medication alone.
Additional factors such as age, sex, genetics, and the presence of other medical conditions (including type 2 diabetes or metabolic syndrome) may influence the rate and extent of weight loss. Regular monitoring and communication with your doctor help ensure that the therapy remains effective and safe throughout your weight management journey.
It is important to note that weight loss with high-dose semaglutide tends to occur gradually, with the most noticeable changes often seen within the first three to six months of treatment. Sustained results are more likely when patients remain committed to both their medication regimen and recommended lifestyle adjustments.
The process of starting once-weekly high-dose semaglutide therapy in Singapore involves medical assessment, personalised dosing schedules, and structured follow-up.
Proper administration and ongoing supervision are essential for safe and effective weight loss results. This section explains how treatment is initiated, how dosing is adjusted, and what patients can expect at each stage of therapy.
Before starting once-weekly high-dose semaglutide therapy in Singapore, a thorough medical assessment is required. This evaluation includes a review of your medical history, current medications, and any underlying health conditions that may influence treatment suitability.
Doctors typically consider this therapy for adults with a body mass index (BMI) of 27 kg/m² or higher when accompanied by at least one weight-related health condition, such as hypertension, type 2 diabetes, or high cholesterol. Individuals with a BMI of 30 kg/m² or greater may be eligible even without additional health issues.
The assessment may also include laboratory investigations, such as blood tests for glucose, cholesterol, and liver or kidney function. This helps ensure that semaglutide therapy is safe and appropriate based on your unique health profile.
Patients with certain conditions, including a history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pancreatitis, or those who are pregnant or breastfeeding, are generally not considered suitable for this medication.
A comprehensive consultation allows your doctor to determine if once-weekly high-dose semaglutide is the most appropriate weight loss strategy, or if alternative therapies should be considered.
Once-weekly high-dose semaglutide therapy is initiated at a low dose to minimise the risk of gastrointestinal side effects. Treatment typically begins with 0.25 mg once per week, administered as a subcutaneous injection.
After four weeks at the starting dose, the dose is gradually increased at four-week intervals. The usual titration schedule progresses from 0.25 mg to 0.5 mg, then to 1.0 mg, followed by 1.7 mg, and finally reaching the maintenance dose of 2.4 mg per week. This stepwise escalation allows the body to adjust gradually, reducing the likelihood of adverse effects such as nausea or abdominal discomfort.
At each titration step, doctors in Singapore monitor patient response, provide instructions for the next dose increase, and address any side effects or concerns. If side effects are significant, the dose may be maintained at the current level for a longer period or temporarily reduced.
Following the prescribed titration schedule is important for both safety and treatment effectiveness. Patients are advised to attend all follow-up appointments and to communicate any side effects or difficulties with their healthcare provider.
A gradual increase in dosage not only improves tolerability but also supports optimal long-term weight loss outcomes with once-weekly high-dose semaglutide therapy.
Proper administration of once-weekly high-dose semaglutide is essential for both safety and effectiveness. This medication is provided in a pre-filled injection pen designed for at-home use following initial training by a healthcare professional.
During your first visit, your doctor or clinic nurse will demonstrate how to use the pen device. Key topics include selecting and rotating injection sites (such as the abdomen or thigh), preparing the device, and performing a subcutaneous injection. Patients are also shown how to dispose of used needles safely.
It is important to inject the medication into a different site each week to reduce the risk of irritation or tissue changes. Most patients find the injection process straightforward and easy to perform.
Ongoing medical supervision at our clinic is essential for successful weight loss with once-weekly high-dose semaglutide therapy. Regular follow-up appointments are scheduled to monitor your progress, review any side effects, and make adjustments to your treatment plan as needed.
During each visit, you will meet with Dr Edwin or one of our experienced doctors, who will assess your weight changes and address any concerns about medication or lifestyle recommendations. Laboratory tests may be conducted periodically to track blood sugar, cholesterol, and other health markers relevant to your weight management journey.
Our clinic uses these follow-up sessions to reinforce healthy eating habits, encourage regular exercise, and provide behavioral support tailored to your goals. If needed, we can arrange for additional resources, such as referrals to dietitians or allied health professionals.
If you experience side effects or find that your weight loss progress has slowed, our doctors can adjust the dose escalation schedule or suggest alternative strategies to keep you on track. Open communication with the clinic team is encouraged, so you always feel supported throughout your treatment.
Consistent follow-up with Dr Edwin and our clinic ensures that your high-dose semaglutide therapy remains safe, effective, and personalised to your needs at every stage.
Gastrointestinal side effects are the most common reactions during high-dose semaglutide therapy. Nausea occurs in up to 40% of patients, while vomiting, diarrhea, and constipation are also reported, particularly during dose escalation. These symptoms are usually temporary and often resolve as the body adjusts to treatment.
To minimize discomfort, our clinic recommends a gradual titration schedule, starting at the lowest dose and increasing every four weeks. Eating smaller meals, avoiding high-fat foods, and staying well hydrated can help manage mild symptoms. Dr Edwin or our doctors may advise slowing the dose escalation or maintaining your current dose for a longer period if symptoms are persistent.
Less commonly, some patients experience abdominal pain, indigestion, or reduced appetite. Severe or persistent vomiting, signs of dehydration, or symptoms such as persistent abdominal pain may indicate rare but serious complications like pancreatitis and should be reported immediately.
Other side effects may include headache, fatigue, dizziness, or mild injection-site reactions. Allergic reactions are very rare but require prompt medical attention.
Patients with a history of gallbladder disease or pancreatitis require careful monitoring, as semaglutide may increase the risk of related complications. Your doctor will review your full medical history before and during therapy.
Our clinic encourages all patients to promptly report any side effects, no matter how mild or severe, so adjustments to your treatment plan can be made to ensure both safety and continued progress with your weight loss journey.
Some patients may already be using other prescription weight loss medications, such as daily liraglutide injections or oral GLP-1 tablets, before considering once-weekly high-dose semaglutide. Transitioning to a new therapy should always be managed by Dr Edwin or our doctors to ensure safety and the best possible results.
It is generally not recommended to use two GLP-1 receptor agonists at the same time. When switching from another GLP-1 therapy, our clinic will advise on an appropriate washout period or timing of the last dose before starting semaglutide. This helps reduce the risk of overlapping side effects and supports a smooth transition.
Patients moving from other types of weight loss medications—such as appetite suppressants, fat absorption blockers, or combination therapies—should also consult our doctors for individual guidance. Your medical history, current medications, and treatment goals will be reviewed to determine the safest and most effective approach.
Ongoing follow-up is important after any change in therapy. Our clinic team will monitor your response to the new medication, check for any side effects, and help you adapt to your new dosing schedule or injection technique.
The length of time a patient remains on once-weekly high-dose semaglutide can vary based on individual weight loss goals, treatment response, and overall health. Many patients continue therapy for at least six to twelve months, with some staying on the medication longer to support weight maintenance or prevent weight regain.
Dr Edwin or our doctors will regularly assess your progress at follow-up appointments and help determine when you may be ready to reduce your dose or transition to a maintenance plan. If you reach your target weight and can maintain it with lifestyle changes, a gradual reduction or cessation of semaglutide may be considered.
It is important not to stop therapy abruptly without consulting our clinic, as this can increase the risk of regaining lost weight. Some patients may need ongoing treatment or additional support to maintain results, especially if there are underlying metabolic conditions or weight regain risk factors.
The decision to continue, reduce, or stop therapy is individualized and based on ongoing assessment by Dr Edwin or our doctors, as well as your personal weight management goals.
Once-weekly high-dose semaglutide therapy is considered safe for most eligible patients when prescribed and monitored by a qualified doctor. However, as with any medication, there are potential risks, side effects, and situations in which this therapy may not be suitable. Understanding these factors helps patients and healthcare providers make informed decisions about treatment.
Most patients experience mild to moderate side effects, especially during the first few weeks or after dose increases. Gastrointestinal symptoms such as nausea, vomiting, diarrhea, constipation, abdominal discomfort, and reduced appetite are the most frequently reported. These side effects are usually temporary and often resolve as your body adapts to the medication.
Other possible effects include headache, dizziness, fatigue, and mild injection-site reactions. Our clinic team will provide you with strategies to minimise discomfort and manage common symptoms. For detailed guidance on coping with these side effects, refer to the section above on “Managing Side Effects and Dose Adjustments.”
Although rare, serious side effects can occur with high-dose semaglutide. Signs of pancreatitis—such as severe and persistent abdominal pain, with or without vomiting—require immediate medical attention. Other rare but serious risks include gallbladder disease, kidney problems related to dehydration, and severe allergic reactions (such as swelling of the face, difficulty breathing, or rash).
Patients are advised to seek urgent care or contact Dr Edwin or our clinic promptly if they experience any severe or unusual symptoms while on this medication.
This therapy is not suitable for everyone. Contraindications include:
Caution is also advised for patients with a history of gallbladder disease, severe gastrointestinal disorders, or kidney impairment. Dr Edwin or our doctors will conduct a thorough assessment to determine if semaglutide is appropriate for your health profile.
Continuous monitoring throughout therapy is essential to maintain patient safety and effectiveness of treatment. Our clinic schedules regular follow-up visits to review your response, adjust dosing if needed, and check for any adverse effects or changes in your health.
Laboratory tests may be repeated periodically to monitor blood sugar, cholesterol, kidney function, and other relevant markers. Open communication with Dr Edwin, our doctors, or the clinic staff helps to address any concerns promptly and ensure optimal outcomes with high-dose semaglutide therapy.
Many patients want to understand how once-weekly high-dose semaglutide compares with other prescription weight loss options available in Singapore. This section outlines the similarities, differences, and key considerations for each alternative, helping you and your doctor choose the best therapy for your needs.
Daily injectable liraglutide is another GLP-1 receptor agonist used for weight loss. While both medications target appetite and metabolic pathways, high-dose semaglutide is administered only once per week, compared to daily injections with liraglutide. Clinical studies have shown that the once-weekly high-dose regimen generally results in greater average weight loss and may be more convenient for those who prefer fewer injections.
Our clinic can advise whether a daily or weekly GLP-1 approach is more suitable based on your weight loss goals, medical history, and lifestyle.
Dual-agonist injectable therapies, such as tirzepatide, are designed to target both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) pathways. This dual mechanism may provide even more pronounced weight loss for some patients. However, availability and specific suitability should be discussed with Dr Edwin or our doctors, as not all options are currently accessible in Singapore.
Both therapies are once-weekly injections, but differ in their active ingredients, mechanisms of action, and side effect profiles.
Oral GLP-1 tablet therapies, such as those containing semaglutide in tablet form, offer an alternative for patients who prefer not to use injections. However, clinical data suggest that injectable forms may produce greater average weight loss than oral tablets. Dosing convenience, individual tolerance, and medical history should be discussed with our doctors to determine the most appropriate choice.
Other prescription weight loss medications, such as appetite suppressants (e.g., phentermine), fat absorption blockers (e.g., orlistat), and combination therapies (e.g., naltrexone/bupropion), act through different mechanisms and have distinct side effect profiles. These medications are not GLP-1 agonists and are often considered for patients who are not candidates for hormone-based therapy, or who have not responded to other treatments.
Dr Edwin or our clinic can explain the benefits, risks, and expectations for each therapy based on your unique needs.
Understanding what to expect throughout your treatment with once-weekly high-dose semaglutide can help you prepare for each stage and set realistic goals. This section outlines the typical timeline and milestones, from your first appointment at our clinic to maintenance and ongoing support.
Your journey begins with a comprehensive consultation at our clinic, where Dr Edwin or one of our doctors will review your medical history, conduct necessary investigations, and determine if once-weekly high-dose semaglutide is suitable for you. This stage may also include baseline measurements and laboratory tests.
During the initial month of therapy, you will start at a low dose and gradually increase according to your doctor’s instructions. Our clinic team will provide injection training, address any questions, and offer support to help you adjust to the new regimen.
Most patients experience mild side effects during this period, which tend to resolve as the body adapts.
Over the next several weeks, your dose will be titrated up to the maintenance level. You’ll attend follow-up appointments for monitoring and support, and begin to see the first signs of weight loss. Our clinic will help you track progress, reinforce lifestyle changes, and manage any ongoing side effects.
Once you reach the maintenance dose, weight loss continues at a steady pace for most patients. Regular follow-up visits help ensure continued success and provide ongoing support for healthy lifestyle habits. Our clinic will work with you to maintain results and address any challenges that may arise during long-term therapy.
If you achieve your target weight or your health goals change, Dr Edwin or our doctors may discuss a plan to gradually reduce or discontinue semaglutide therapy. Our clinic will help you transition to a maintenance program and provide strategies to prevent weight regain, ensuring that your weight management success is sustained for the long term.
How Do High-Dose Semaglutide Once-Weekly Weight Loss Injections Work?
High-dose semaglutide, as used in Wegovy, is a GLP-1 receptor agonist that helps regulate appetite, increase feelings of fullness, and decrease overall calorie intake. By mimicking the action of natural gut hormones, it slows gastric emptying and reduces hunger signals to the brain. This results in gradual, clinically supervised weight loss when the medication is combined with a healthy diet and regular physical activity. Most patients are prescribed Wegovy as part of a comprehensive medical weight management plan at our clinic.
How Do High-Dose Semaglutide Once-Weekly Weight Loss Injections Work?
High-dose semaglutide, as used in Wegovy, is a GLP-1 receptor agonist that helps regulate appetite, increase feelings of fullness, and decrease overall calorie intake. By mimicking the action of natural gut hormones, it slows gastric emptying and reduces hunger signals to the brain. This results in gradual, clinically supervised weight loss when the medication is combined with a healthy diet and regular physical activity. Most patients are prescribed Wegovy as part of a comprehensive medical weight management plan at our clinic.
Who Is Eligible for High-Dose Semaglutide Weight Loss Injections?
High-dose semaglutide injections are generally suitable for adults in Singapore with a BMI of 27 kg/m² or higher and a weight-related medical condition, or for those with a BMI over 30 kg/m². Eligibility is determined through a detailed medical assessment with Dr Edwin or our clinic doctors, taking into account your overall health, medical history, and current medications. Not all patients will be suitable candidates; contraindications and individual risk factors must be considered.
What Results Can I Expect From Once-Weekly High-Dose Semaglutide Therapy?
Most patients using Wegovy for weight management can expect to lose up to 15% of their initial body weight over approximately 68 weeks, according to clinical trial data. Actual results vary depending on adherence to the treatment plan, lifestyle changes, and individual metabolic factors. Sustained weight loss is more likely when medication is paired with dietary modification, increased physical activity, and ongoing support from our clinic team.
What Are the Most Common Side Effects of High-Dose Semaglutide Injections?
The most common side effects of Wegovy are gastrointestinal, including nausea, vomiting, diarrhea, constipation, and abdominal pain. Headache, fatigue, and mild injection-site reactions are also possible. Most side effects are temporary and tend to resolve as your body adjusts to the medication, particularly when the dose is increased gradually. Our clinic provides advice and support to help manage any symptoms and improve your experience with treatment.
How Safe Is Long-Term Use of High-Dose Semaglutide for Weight Loss?
Wegovy has been studied in large-scale clinical trials for up to two years and has shown sustained weight loss and a stable safety profile. Long-term safety monitoring is important, and patients are encouraged to attend regular follow-ups at our clinic for ongoing assessment. Rare but serious risks, such as pancreatitis or gallbladder disease, are carefully monitored by Dr Edwin and our team.
Can High-Dose Semaglutide Be Used With Other Weight Loss Medications?
It is generally not recommended to combine Wegovy with other GLP-1 medications such as Ozempic, Saxenda, Mounjaro, or Rybelsus, as this may increase the risk of side effects. If you are currently using another prescription weight loss medication, discuss with Dr Edwin or our clinic about safe transition strategies. Each patient’s plan is customized for the best outcome and safety.
What If I Miss a Dose of My Once-Weekly Injection?
If you miss a scheduled Wegovy injection, take it as soon as possible within five days of the missed dose. If more than five days have passed, skip the missed dose and resume your regular schedule. Consistency is important for effectiveness, so set reminders if needed, and contact our clinic if you are unsure how to proceed.
How Long Will I Need to Stay on High-Dose Semaglutide Injections?
The length of Wegovy therapy depends on your weight loss progress and overall health goals. Most patients remain on high-dose semaglutide for six to twelve months, though some may need longer-term treatment for weight maintenance. Regular review appointments at our clinic help determine when it’s appropriate to adjust or discontinue therapy.
Is Weight Regain Likely After Stopping High-Dose Semaglutide Therapy?
Weight regain is possible after stopping Wegovy, especially if healthy lifestyle habits are not maintained. To minimize this risk, our clinic provides structured follow-up and support, helping you develop sustainable strategies for long-term weight management even after medication is discontinued.
What Is the Cost of High-Dose Semaglutide Once-Weekly Weight Loss Injections in Singapore?
The cost of Wegovy in Singapore can vary depending on dosage, clinic, and supply availability. Patients are encouraged to contact our clinic for current pricing and package options.
Do I Need a Prescription for Once-Weekly High-Dose Semaglutide in Singapore?
Yes, Wegovy is a prescription-only medication in Singapore and must be prescribed by a licensed medical professional. Our clinic provides a comprehensive medical assessment to determine if this therapy is suitable for you and will guide you through every step of treatment and monitoring.
Can I Use High-Dose Semaglutide Injections If I Have Other Medical Conditions?
Patients with certain health conditions, such as pancreatitis, a history of thyroid cancer, or severe kidney or liver problems, may not be suitable for Wegovy. Dr Edwin or our doctors will conduct a thorough review of your medical history before starting therapy to ensure your safety.
Is It Safe to Use Once-Weekly Semaglutide Injections During Pregnancy or Breastfeeding?
Wegovy is not recommended for women who are pregnant, planning to become pregnant, or breastfeeding. If you become pregnant while on this medication, inform Dr Edwin or our clinic immediately so we can review your treatment plan.
How Should I Store My High-Dose Semaglutide Injection Pens?
Wegovy injection pens should be stored in the refrigerator (2°C to 8°C) before first use. Always keep pens out of direct sunlight and away from children.
Can I Travel Overseas With My Once-Weekly Semaglutide Injections?
Yes, you can travel with Wegovy pens, but it is important to keep them cool and carry a copy of your prescription or a letter from Dr Edwin or our clinic, especially when flying or crossing borders. Check airline policies for carrying injectable medications and inform our clinic if you need travel documentation.
What Happens If I Experience Severe Side Effects From Weekly Injections?
If you experience severe side effects such as persistent vomiting, severe abdominal pain, signs of dehydration, or symptoms of an allergic reaction, contact Dr Edwin or our clinic immediately or seek urgent medical attention. Our team will provide guidance and make necessary adjustments to your treatment plan.
Can Once-Weekly High-Dose Semaglutide Be Used for Weight Maintenance After Weight Loss?
Wegovy can be continued for weight maintenance in patients who have achieved their target weight, as long as it remains clinically appropriate. Ongoing monitoring at our clinic ensures safe long-term use and helps prevent weight regain.
Are There Any Dietary Restrictions While Using High-Dose Semaglutide?
No specific foods are strictly prohibited, but a balanced, healthy diet low in processed foods and high in fruits, vegetables, and lean proteins is recommended for best results. Our clinic provides personalized dietary advice to support your weight loss and minimize side effects while on Wegovy.
Copyrights 2025 by Edwin Lim Medical Aesthetic Clinic Pte. Ltd.
